Monthly Archives: September 2013

Cui Bono? Finding Super Responders In Clinical Trials

I’m a voracious reader of mysteries in my spare time.  And some juncture in every story, as the detective finds himself staring at the corpse, they ask the inevitable question “Cui Bono — who benefits?”  Oddly enough, this is a … Continue reading

Posted in Cancer Research, Drug Development, Informatics, pancreatic cancer | Tagged , , | Leave a comment

Abraxane Approved For Treatment of Pancreatic Cancer

The FDA recently approved Abraxane for the treatment of metastatic pancreatic cancer. This is a breakthrough for Celgene (who acquired the drug with their acquisition of Abraxis), and is the first significant change in the treatment of pancreatic cancer in … Continue reading

Posted in pancreatic cancer | Tagged , | Leave a comment

Tinkering with OntoMaton

One of the primary challenges in open science is making the experiment data behind a paper easily accessible in a universally acceptable format.  A number of solutions have sprung up over the years to address parts of this problem; however, … Continue reading

Posted in Informatics, Semantic Web | Tagged , , , | 1 Comment